BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30398015)

  • 1. Rituximab-associated posterior reversible encephalopathy syndrome.
    Mustafa KN; Qasem U; Al-Ryalat NT; Bsisu IK
    Int J Rheum Dis; 2019 Jan; 22(1):160-165. PubMed ID: 30398015
    [No Abstract]   [Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome in a patient with lupus nephritis on rituximab therapy: a challenge to find the offender.
    Mondal S; Goswami RP; Sinha D; Basu K; Das S; Ghosh P; Ghosh A
    Lupus; 2016 Apr; 25(4):445-6. PubMed ID: 26405025
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible posterior leukoencephalopathy syndrome after rituximab.
    Zito JA; Lee CC; Johnson S; Singer A; Vacirca J
    Am J Emerg Med; 2010 May; 28(4):537.e1-2. PubMed ID: 20466257
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide.
    Jabrane M; Ait Lahcen Z; Fadili W; Laouad I
    Rheumatol Int; 2015 May; 35(5):935-8. PubMed ID: 25387825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.
    Zekić T; Benić MS; Antulov R; Antončić I; Novak S
    Rheumatol Int; 2017 Dec; 37(12):2105-2114. PubMed ID: 29043491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome in a patient with mixed connective tissue disease: a case report.
    Rahmanzadeh R; Rahmanzade R; Zabihiyeganeh M
    J Med Case Rep; 2016 Jun; 10(1):145. PubMed ID: 27250498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-Associated Posterior Reversible Encephalopathy Syndrome in Renal Transplant Recipient in Early Posttransplant Period: Case Report.
    Hassan SMA
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):336-337. PubMed ID: 38385421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdose of Tacrolimus as the Trigger Causing Progression of Posterior Reversible Encephalopathy Syndrome and Subsequent Hepatic Infarction After Liver Transplant: A Case Report.
    Tseng WC; Lai HC; Yeh CC; Fan HL; Wu ZF
    Exp Clin Transplant; 2020 Feb; 18(1):128-132. PubMed ID: 30602365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible Lesions of Tacrolimus-induced Posterior Reversible Leukoencephalopathy Syndrome.
    Savaj S; Farasatinasab M; Amouzegar A
    Iran J Kidney Dis; 2017 Nov; 11(6):408. PubMed ID: 29190599
    [No Abstract]   [Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome: a case study.
    Wright KL; Polito MH; French AE
    Am J Nurs; 2012 May; 112(5):36-40; quiz 41-2. PubMed ID: 22546734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome.
    Khajuria B; Khajuria M; Agrawal Y
    Am J Ther; 2016; 23(4):e1072-3. PubMed ID: 25933141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis.
    Zhang YX; Liu JR; Ding MP; Huang J; Zhang M; Jansen O; Deuschl G; Eschenfelder CC
    Intern Med; 2008; 47(9):867-75. PubMed ID: 18451582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset neutropenia and thrombocytopenia following rituximab in lupus nephritis.
    Shah S; Kavadichanda CG; Belani P; Ganesh RN; Negi VS
    Int J Rheum Dis; 2019 May; 22(5):946-950. PubMed ID: 30168270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus nephritis with posterior reversible encephalopathy syndrome as the first manifestation.
    Wang WJ; Chen WH; Zhao XQ; Wu XX
    QJM; 2023 Dec; 116(12):1018-1019. PubMed ID: 37676823
    [No Abstract]   [Full Text] [Related]  

  • 15. Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy.
    Kapoor A; Birks E; Lenneman A; McCants K
    Tex Heart Inst J; 2017 Jun; 44(3):205-208. PubMed ID: 28761402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus following methylprednisolone: report of two cases.
    Chennareddy S; Adapa R; Kishore BK; Rajasekhar L
    Int J Rheum Dis; 2013 Dec; 16(6):786-8. PubMed ID: 24131800
    [No Abstract]   [Full Text] [Related]  

  • 17. Posterior reversible encephalopathy syndrome in a patient with lupus nephritis.
    Kadikoy H; Haque W; Hoang V; Maliakkal J; Nisbet J; Abdellatif A
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):572-6. PubMed ID: 22569448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome after first rituximab transfusion for treatment of granulomatosis with polyangiitis.
    Gong Y; Lam A; Paul V
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35550327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant lymphoma complicated with posterior reversible encephalopathy].
    Thomsen RH; Zakarian K; Hansen PB
    Ugeskr Laeger; 2015 Sep; 177(37):V03150236. PubMed ID: 26376238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
    Iwata S; Saito K; Hirata S; Ohkubo N; Nakayamada S; Nakano K; Hanami K; Kubo S; Miyagawa I; Yoshikawa M; Miyazaki Y; Yoshinari H; Tanaka Y
    Lupus; 2018 Apr; 27(5):802-811. PubMed ID: 29308726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.